|
|
28 Feb 2003
Deloitte made the decision public late Friday afternoon that it would part company with the controversial drug testing labs following more than a week of high profile protests by SHAC and other action by sympathetic groups.
John Connolly, Deloitte & Touche's senior partner said: 'Having completed the audit for 2002, we will not be offering ourselves for re-election as auditors to Huntingdon Life Sciences.'
But Greg Avery, SHAC co-ordinator, said that the climb down was not enough to stop the protests. 'If the latest annual report comes out of HLS with Deloitte's name on it (as auditor) then we will still consider them to be the company's auditors,' he said.
You may also like
Search thousands of financial jobs:
Search thousands of financial jobs:
Careers
Search for jobs
Click to search our database of all the latest accountancy roles
Create a profile
Click to set up your profile and let the best recruiters find you
Jobs by email
Sign up to receive regular updates with the latest roles suitable for you
Briefings
By looking at the reasons supplier statements became unfashionable, and the reasons why it is different today, this paper delves into the many benefits that can be obtained by automating the process.
Having a real and true view of your organisation’s current financial position, and having the right systems and processes in place, will ensure that you can make strong choices and are ready to capitalise on opportunities
AccountancyAgeInsight is a frequently updated resource centre for finance professionals, offering a free and easy-to-use digital library of briefings, white papers and other information resources. 
Visitor comments Add your comment